Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2001-03

AUTHORS

Horng H. Chen, Alessandro Cataliotti, John C. Burnett

ABSTRACT

Vasopeptidase (VP) inhibitors are novel molecules that coinhibit neutral endopeptidase 24.11 (NEP), which degrades natriuretic peptides and angiotensin-converting enzyme (ACE). We review the biology of the natriuretic peptide system and a recent study of the role for the natriuretic peptide system in the mechanism of action of omapatrilat (the most clinically advanced VP inhibitor). This study compared the cardiorenal and humoral actions of omapatrilat with those of ACE inhibition. The actions of omapatrilat were further defined in the presence and absence of a natriuretic peptide receptor antagonist. This investigation provided insight into a unique new pharmacologic agent that has beneficial renal actions in experimental mild heart failure that exceed those seen with ACE inhibition alone and that are linked to the natriuretic peptide system. More... »

PAGES

s15-s21

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y

DOI

http://dx.doi.org/10.1007/s11906-001-0102-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1053694779

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/11716801


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Angiotensin-Converting Enzyme Inhibitors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Atrial Natriuretic Factor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cardiovascular Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Heart Failure", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Kidney", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neprilysin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyridines", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Thiazepines", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Horng H.", 
        "id": "sg:person.01024326700.50", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cataliotti", 
        "givenName": "Alessandro", 
        "id": "sg:person.015220345407.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015220345407.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA", 
          "id": "http://www.grid.ac/institutes/grid.66875.3a", 
          "name": [
            "Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Burnett", 
        "givenName": "John C.", 
        "id": "sg:person.01001266776.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/s11886-000-0069-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1026762752", 
          "https://doi.org/10.1007/s11886-000-0069-3"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2001-03", 
    "datePublishedReg": "2001-03-01", 
    "description": "Vasopeptidase (VP) inhibitors are novel molecules that coinhibit neutral endopeptidase 24.11 (NEP), which degrades natriuretic peptides and angiotensin-converting enzyme (ACE). We review the biology of the natriuretic peptide system and a recent study of the role for the natriuretic peptide system in the mechanism of action of omapatrilat (the most clinically advanced VP inhibitor). This study compared the cardiorenal and humoral actions of omapatrilat with those of ACE inhibition. The actions of omapatrilat were further defined in the presence and absence of a natriuretic peptide receptor antagonist. This investigation provided insight into a unique new pharmacologic agent that has beneficial renal actions in experimental mild heart failure that exceed those seen with ACE inhibition alone and that are linked to the natriuretic peptide system.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s11906-001-0102-y", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2384951", 
        "type": "MonetaryGrant"
      }, 
      {
        "id": "sg:grant.2532198", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1021183", 
        "issn": [
          "1522-6417", 
          "1534-3111"
        ], 
        "name": "Current Hypertension Reports", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "Suppl 2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "3"
      }
    ], 
    "keywords": [
      "natriuretic peptide system", 
      "angiotensin-converting enzyme", 
      "humoral actions", 
      "heart failure", 
      "natriuretic peptide", 
      "ACE inhibition", 
      "natriuretic peptide receptor antagonist", 
      "peptide system", 
      "beneficial renal actions", 
      "mild heart failure", 
      "peptide receptor antagonist", 
      "experimental heart failure", 
      "new pharmacologic agents", 
      "mechanism of action", 
      "renal actions", 
      "vasopeptidase inhibitor", 
      "receptor antagonist", 
      "pharmacologic agents", 
      "omapatrilat", 
      "Recent studies", 
      "inhibition", 
      "novel molecules", 
      "failure", 
      "action", 
      "antagonist", 
      "peptides", 
      "study", 
      "role", 
      "inhibitors", 
      "agents", 
      "absence", 
      "presence", 
      "enzyme", 
      "mechanism", 
      "biology", 
      "insights", 
      "investigation", 
      "system", 
      "molecules", 
      "unique new pharmacologic agent", 
      "experimental mild heart failure"
    ], 
    "name": "Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure", 
    "pagination": "s15-s21", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1053694779"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s11906-001-0102-y"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "11716801"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s11906-001-0102-y", 
      "https://app.dimensions.ai/details/publication/pub.1053694779"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T18:11", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_331.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s11906-001-0102-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s11906-001-0102-y'


 

This table displays all metadata directly associated to this object as RDF triples.

165 TRIPLES      22 PREDICATES      79 URIs      70 LITERALS      17 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s11906-001-0102-y schema:about N1701c2193739492cb06ea9ae888a49fb
2 N6e6a58d6d3f04456b9e94f7e10850398
3 N80ffd473dd3b46d694acbf9fa5411ce2
4 N94e3056c8652441181f2acd40fafa6d5
5 N9f9c70f4576f4e06b65cce0525603825
6 Nacba240dcee64d9fbd29a367100cacf6
7 Ndb2b1882075943c397a03932d66d5b47
8 Neae0575507644ab7a5e5cf9f84ca489a
9 Neca82806cd754b92802f10d54099f3f4
10 Nedcc1c7669634368a5b046b26d2af9be
11 anzsrc-for:11
12 anzsrc-for:1102
13 schema:author Nefc43d27d5074928b5b2ac097ef7567c
14 schema:citation sg:pub.10.1007/s11886-000-0069-3
15 schema:datePublished 2001-03
16 schema:datePublishedReg 2001-03-01
17 schema:description Vasopeptidase (VP) inhibitors are novel molecules that coinhibit neutral endopeptidase 24.11 (NEP), which degrades natriuretic peptides and angiotensin-converting enzyme (ACE). We review the biology of the natriuretic peptide system and a recent study of the role for the natriuretic peptide system in the mechanism of action of omapatrilat (the most clinically advanced VP inhibitor). This study compared the cardiorenal and humoral actions of omapatrilat with those of ACE inhibition. The actions of omapatrilat were further defined in the presence and absence of a natriuretic peptide receptor antagonist. This investigation provided insight into a unique new pharmacologic agent that has beneficial renal actions in experimental mild heart failure that exceed those seen with ACE inhibition alone and that are linked to the natriuretic peptide system.
18 schema:genre article
19 schema:inLanguage en
20 schema:isAccessibleForFree false
21 schema:isPartOf N1d8065d952bd4814b3c7b48d4300c6ec
22 Na2ff645801dc47798e451991ba2f87ef
23 sg:journal.1021183
24 schema:keywords ACE inhibition
25 Recent studies
26 absence
27 action
28 agents
29 angiotensin-converting enzyme
30 antagonist
31 beneficial renal actions
32 biology
33 enzyme
34 experimental heart failure
35 experimental mild heart failure
36 failure
37 heart failure
38 humoral actions
39 inhibition
40 inhibitors
41 insights
42 investigation
43 mechanism
44 mechanism of action
45 mild heart failure
46 molecules
47 natriuretic peptide
48 natriuretic peptide receptor antagonist
49 natriuretic peptide system
50 new pharmacologic agents
51 novel molecules
52 omapatrilat
53 peptide receptor antagonist
54 peptide system
55 peptides
56 pharmacologic agents
57 presence
58 receptor antagonist
59 renal actions
60 role
61 study
62 system
63 unique new pharmacologic agent
64 vasopeptidase inhibitor
65 schema:name Role of the natriuretic peptides in the cardiorenal and humoral actions of omapatrilat: Insights from experimental heart failure
66 schema:pagination s15-s21
67 schema:productId N494fb15c28644b8bb5353731b69de34b
68 N6cd33e208255469082aa45915dee43f8
69 N84376b32566742e8ae2775c92ba19207
70 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053694779
71 https://doi.org/10.1007/s11906-001-0102-y
72 schema:sdDatePublished 2022-01-01T18:11
73 schema:sdLicense https://scigraph.springernature.com/explorer/license/
74 schema:sdPublisher N1fb0c1e66bbc4f31bb661e7263d1481f
75 schema:url https://doi.org/10.1007/s11906-001-0102-y
76 sgo:license sg:explorer/license/
77 sgo:sdDataset articles
78 rdf:type schema:ScholarlyArticle
79 N1701c2193739492cb06ea9ae888a49fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Animals
81 rdf:type schema:DefinedTerm
82 N1d8065d952bd4814b3c7b48d4300c6ec schema:issueNumber Suppl 2
83 rdf:type schema:PublicationIssue
84 N1fb0c1e66bbc4f31bb661e7263d1481f schema:name Springer Nature - SN SciGraph project
85 rdf:type schema:Organization
86 N494fb15c28644b8bb5353731b69de34b schema:name pubmed_id
87 schema:value 11716801
88 rdf:type schema:PropertyValue
89 N6cd33e208255469082aa45915dee43f8 schema:name doi
90 schema:value 10.1007/s11906-001-0102-y
91 rdf:type schema:PropertyValue
92 N6e6a58d6d3f04456b9e94f7e10850398 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Angiotensin-Converting Enzyme Inhibitors
94 rdf:type schema:DefinedTerm
95 N71cfa12ba6d945d6b07d4a9a983a0242 rdf:first sg:person.015220345407.74
96 rdf:rest Nfba6c164d2cf48f0a7273bda81980c50
97 N80ffd473dd3b46d694acbf9fa5411ce2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
98 schema:name Pyridines
99 rdf:type schema:DefinedTerm
100 N84376b32566742e8ae2775c92ba19207 schema:name dimensions_id
101 schema:value pub.1053694779
102 rdf:type schema:PropertyValue
103 N94e3056c8652441181f2acd40fafa6d5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Cardiovascular Agents
105 rdf:type schema:DefinedTerm
106 N9f9c70f4576f4e06b65cce0525603825 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 Na2ff645801dc47798e451991ba2f87ef schema:volumeNumber 3
110 rdf:type schema:PublicationVolume
111 Nacba240dcee64d9fbd29a367100cacf6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
112 schema:name Atrial Natriuretic Factor
113 rdf:type schema:DefinedTerm
114 Ndb2b1882075943c397a03932d66d5b47 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Heart Failure
116 rdf:type schema:DefinedTerm
117 Neae0575507644ab7a5e5cf9f84ca489a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Neprilysin
119 rdf:type schema:DefinedTerm
120 Neca82806cd754b92802f10d54099f3f4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
121 schema:name Kidney
122 rdf:type schema:DefinedTerm
123 Nedcc1c7669634368a5b046b26d2af9be schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
124 schema:name Thiazepines
125 rdf:type schema:DefinedTerm
126 Nefc43d27d5074928b5b2ac097ef7567c rdf:first sg:person.01024326700.50
127 rdf:rest N71cfa12ba6d945d6b07d4a9a983a0242
128 Nfba6c164d2cf48f0a7273bda81980c50 rdf:first sg:person.01001266776.01
129 rdf:rest rdf:nil
130 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
131 schema:name Medical and Health Sciences
132 rdf:type schema:DefinedTerm
133 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
134 schema:name Cardiorespiratory Medicine and Haematology
135 rdf:type schema:DefinedTerm
136 sg:grant.2384951 http://pending.schema.org/fundedItem sg:pub.10.1007/s11906-001-0102-y
137 rdf:type schema:MonetaryGrant
138 sg:grant.2532198 http://pending.schema.org/fundedItem sg:pub.10.1007/s11906-001-0102-y
139 rdf:type schema:MonetaryGrant
140 sg:journal.1021183 schema:issn 1522-6417
141 1534-3111
142 schema:name Current Hypertension Reports
143 schema:publisher Springer Nature
144 rdf:type schema:Periodical
145 sg:person.01001266776.01 schema:affiliation grid-institutes:grid.66875.3a
146 schema:familyName Burnett
147 schema:givenName John C.
148 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001266776.01
149 rdf:type schema:Person
150 sg:person.01024326700.50 schema:affiliation grid-institutes:grid.66875.3a
151 schema:familyName Chen
152 schema:givenName Horng H.
153 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024326700.50
154 rdf:type schema:Person
155 sg:person.015220345407.74 schema:affiliation grid-institutes:grid.66875.3a
156 schema:familyName Cataliotti
157 schema:givenName Alessandro
158 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015220345407.74
159 rdf:type schema:Person
160 sg:pub.10.1007/s11886-000-0069-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1026762752
161 https://doi.org/10.1007/s11886-000-0069-3
162 rdf:type schema:CreativeWork
163 grid-institutes:grid.66875.3a schema:alternateName Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA
164 schema:name Cardiorenal Research Laboratory, Mayo Clinic and Foundation, Guggenheim 915, 200 First Street SW, 55905, Rochester, MN, USA
165 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...